Gliomas are a deadly primary malignant tumor of the central nervous system, with
glioblastoma (GBM) representing the most aggressive type. The clinical prognosis of GBM …

Background Glioblastoma is the most common primary malignant brain tumor in adults.
TTFields is a therapy that use intermediate‐frequency and low‐intensity alternating electric …

Background Tumor treating fields (TTF) is the latest treatment for GBM. Circular RNA
(circRNA) has been demonstrated to play critical roles in tumorigenesis. However, the …

Recent studies have verified that circRNAs (circular RNAs) play a critical role in glioma
occurrence and malignant progression. However, numerous circRNAs with unknown …

Background Malignant brain tumors are among the most threatening diseases of the central
nervous system, and despite increasingly updated treatments, the prognosis has not been …

Introduction There is an ongoing scientific discussion, that anti-cancer effects induced by
radiofrequency (RF)-hyperthermia might not be solely attributable to subsequent …

Background: Glioblastoma, a highly aggressive brain tumor, poses a significant clinical
challenge, particularly in the context of radiotherapy. In this study, we aimed to explore …

Abstract Tumor-Treating Fields (TTFields) use intermediate-frequency and low-intensity
electric fields to inhibit tumor cells. However, their mechanisms are still not well understood …

Tumor treating fields (TTFields) therapy is a novel and effective noninvasive cancer therapy,
and it has been approved by FDA in the treatment of recurrent and newly diagnosed …

As the most prevalent brain tumor, glioma is malignant with poor prognostic outcomes. As a
result, it is of great importance to detect biomarkers for glioma diagnosis and prognosis. In …